News
The Avicenna Alliance Publishes its Fourth Edition of the In Silico Medicine Glossary
The Avicenna Alliance is pleased to announce the release of its Fourth Edition of the Avicenna Alliance Glossary, an essential resource aimed at defining and clarifying key concepts in the field of in silico medicine.
Welcome on Board, Hemolens Diagnostics!
We are delighted to welcome Hemolens Diagnostics as a new member of the Avicenna Alliance!
Poll on Computer Modelling & Simulation
The Avicenna Clinical Deployment Task Force, led by Co-Chairs Erica Beaucage-Gauvreau & René Bombien, is engaged to grow a network of professionals with expertise in clinical applications of in silico methodologies, to foster collaboration and knowledge exchange.
April 8th - Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development
Join Next Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development! The EU-funded ERAMET project is transforming how orphan and paediatric medicines are developed. By integrating advanced Computational Modelling & Simulation (CM&S) techniques with real-world data, ERAMET is building a transparent ecosystem to support both medicine developers and regulators.
Avicenna Alliance at the IMDRF meeting in Japan – 10/14 March 2025
This year's International Medical Device Regulators Forum (IMDRF) was organized by the PMDA, taking place in Tokyo.
Avicenna Alliance Submits MDR Revision Proposals to the European Commission
The Avicenna Alliance is pleased to announce that, in a letter sent to the European Commissioner for Health and Animal Welfare, Olivér Várhelyi, we have formally submitted our proposals for the revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) to the European Commission.
